These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7572383)

  • 1. CD4+ and CD8+ T lymphocyte activation in HIV infection. Implications for immune pathogenesis and therapy.
    Laurence J
    Adv Exp Med Biol; 1995; 374():1-15. PubMed ID: 7572383
    [No Abstract]   [Full Text] [Related]  

  • 2. Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy.
    Petrovas C; Mueller YM; Katsikis PD
    Cell Death Differ; 2005 Aug; 12 Suppl 1():859-70. PubMed ID: 15818412
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of T cell activation, HIV replication and hepatitis C virus infection on neutrophil CD64 expression.
    Morquin D; Tuaillon E; Makinson A; Bendriss S; Le Moing V; Reynes J
    Cytometry B Clin Cytom; 2017 Nov; 92(6):492-497. PubMed ID: 27221825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells.
    Catalfamo M; Di Mascio M; Hu Z; Srinivasula S; Thaker V; Adelsberger J; Rupert A; Baseler M; Tagaya Y; Roby G; Rehm C; Follmann D; Lane HC
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19851-6. PubMed ID: 19060209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Battling the enemy on many fronts: inside the science of HIV vaccine development.
    Talley A; Chang S
    Body Posit; 2004; 17(4):8-12. PubMed ID: 15929208
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual.
    Montefiori DC; Altfeld M; Lee PK; Bilska M; Zhou J; Johnston MN; Gao F; Walker BD; Rosenberg ES
    J Immunol; 2003 Apr; 170(7):3906-14. PubMed ID: 12646660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life and death as a T lymphocyte: from immune protection to HIV pathogenesis.
    Vrisekoop N; Mandl JN; Germain RN
    J Biol; 2009; 8(10):91. PubMed ID: 19951397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.
    Kovacs JA; Lempicki RA; Sidorov IA; Adelsberger JW; Herpin B; Metcalf JA; Sereti I; Polis MA; Davey RT; Tavel J; Falloon J; Stevens R; Lambert L; Dewar R; Schwartzentruber DJ; Anver MR; Baseler MW; Masur H; Dimitrov DS; Lane HC
    J Exp Med; 2001 Dec; 194(12):1731-41. PubMed ID: 11748275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy rebuttal. HIV vaccine trial justified.
    McNeil JG; Johnston MI; Birx DL; Tramont EC
    Science; 2004 Feb; 303(5660):961. PubMed ID: 14963313
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new veil removed from the physiologic mysteries of "HIV control" ].
    Nau JY
    Rev Med Suisse; 2007 Apr; 3(107):1017. PubMed ID: 17526378
    [No Abstract]   [Full Text] [Related]  

  • 14. Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations.
    Shete A; Thakar M; Singh DP; Gangakhedkar R; Gaikwad A; Pawar J; Paranjape R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):835-43. PubMed ID: 21936714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group.
    Livingstone WJ; Moore M; Innes D; Bell JE; Simmonds P
    Lancet; 1996 Sep; 348(9028):649-54. PubMed ID: 8782755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
    García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
    J Virol; 2017 May; 91(9):. PubMed ID: 28179536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents.
    Pahwa S; Chitnis V; Mitchell RM; Fernandez S; Chandrasekharan A; Wilson CM; Douglas SD
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):487-95. PubMed ID: 12882658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss.
    Watkins RL; Foster JL; Garcia JV
    Retrovirology; 2015 Jul; 12():61. PubMed ID: 26169178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.